Skip to main content
. 2021 Feb 18;20:46. doi: 10.1186/s12933-021-01238-1

Table 1.

Baseline characteristics according to quartiles of baseline TyG index

Variable Total TyG index P value
Quartile 1 (3.61–8.18) Quartile 2 (8.18–8.57) Quartile 3 (8.57–9.05) Quartile 4 (9.05–12.50)
Participants, n 97,653 24,412 24,414 24,415 24,412
Age, years 51.67 (43.53–58.97) 50.62 (41.69–58.57) 51.68 (43.52–58.97) 52.19 (44.13–59.44) 52.05 (44.33–58.74) < 0.001
Male, n (%) 77,748 (79.62) 18,013 (73.79) 19,350 (79.26) 19,839 (81.26) 20,546 (84.16) < 0.001
High school or above, n (%) 19,064 (20.21) 5751 (24.50) 4556 (19.23) 4526 (19.21) 4231 (17.94) < 0.001
Income > 800 Renminbi/month, n (%) 13,466 (14.29) 3641 (15.52) 3172 (13.40) 3315 (14.07) 3338 (14.16) < 0.001
Body mass index, kg/m2 24.84 (22.60–27.22) 23.14 (21.11–25.32) 24.44 (22.39–26.64) 25.43 (23.41–27.66) 26.30 (24.22–28.41) < 0.001
Systolic blood pressure, mm Hg 130.00 (119.30–140.70) 120.00 (110.00–135.00) 129.30 (116.70–140.00) 130.00 (120.00–143.30) 131.30 (120.00–150.00) < 0.001
Diastolic blood pressure, mm Hg 80.00 (78.70–90.00) 80.00 (70.70–85.00) 80.00 (77.30–90.00) 80.70 (79.30–90.00) 85.00 (80.00–92.00) < 0.001
Current smoker, n (%) 32,577 (34.26) 7876 (33.34) 7615 (31.94) 8160 (34.29) 8926 (37.47) < 0.001
Current alcohol use, n (%) 35,613 (37.44) 8839 (37.40) 8309 (34.84) 8867 (37.25) 9598 (40.28) < 0.001
Active physical activity, n (%) 85,899 (91.27) 21,392 (91.35) 21,682 (91.75) 21,366 (90.82) 21,459 (91.16) 0.004
Myocardial infarction, n (%) 1105 (1.13) 196 (0.80) 245 (1.00) 312 (1.28) 352 (1.44) < 0.001
Diabetes Mellitus, n (%) 2860 (2.93) 175 (0.72) 311 (1.27) 625 (2.56) 1749 (7.17) < 0.001
Hypertension, n (%) 11,450 (11.73) 1720 (7.05) 2379 (9.74) 3255 (13.33) 4096 (16.78) < 0.001
Hypercholesterolemia, n (%) 5429 (5.56) 691 (2.83) 996 (4.08) 1519 (6.22) 2223 (9.11) < 0.001
Fasting plasma glucose, mmol/L 5.11 (4.66–5.71) 4.78 (4.38–5.20) 5.01 (4.62–5.46) 5.24 (4.80–5.81) 5.66 (5.02–6.90) < 0.001
Triglycerides, mmol/L 1.27 (0.89–1.93) 0.70 (0.58–0.82) 1.10 (0.98–1.22) 1.56 (1.36–1.79) 2.77 (2.18–3.90) < 0.001
HDL-C, mmol/L 1.51 (1.28–1.77) 1.54 (1.30–1.80) 1.53 (1.31–1.77) 1.49 (1.27–1.74) 1.47 (1.25–1.75) < 0.001
LDL-C, mmol/L 2.33 (1.82–2.83) 2.13 (1.60–2.72) 2.38 (1.92–2.82) 2.41 (1.97–2.90) 2.38 (1.82–2.88) < 0.001
Hs-CRP, mg/L 0.80 (0.30–2.19) 0.60 (0.21–1.90) 0.72 (0.29–2.00) 0.88 (0.33–2.20) 1.03 (0.40–2.63) < 0.001
TyG index 8.58 (8.18–9.05) 7.91 (7.70–8.06) 8.39 (8.29–8.48) 8.79 (8.68–8.91) 9.46 (9.23–9.82) < 0.001
Antidiabetic drugs, n (%) 2185 (2.24) 131 (0.54) 224 (0.92) 478 (1.96) 1352 (5.54) < 0.001
Lipid-lowering drugs, n (%) 796 (0.82) 93 (0.38) 158 (0.65) 187 (0.77) 358 (1.47) < 0.001
Antihypertensive drugs, n (%) 9895 (10.13) 1484 (6.08) 2036 (8.34) 2840 (11.63) 3535 (14.48) < 0.001

Data are given as median (interquartile range) unless otherwise indicated

HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Hs-CRP high-sensitive C-reactive protein, TyG index triglyceride-glucose